Joachim Dittrich appoints new Chief Representative of Optima

Joachim Dittrich has been appointed as Chief Representative of Optima, effective from February 2018.

The machine engineer will be responsible for the development and internationalisation, particularly for Optima Consumer, as well as for additional subsidiaries and holdings nationwide and internationally.

The area of responsibility includes the strategic orientation and development of these business sections and the development of prospects and synergies.

Dittrich will assume a large part of Hans Bühler’s the CEO, tasks for the Optima Consumer division. Hans Bühler will dedicate more of his time to overall tasks and topics regarding the consortium.

Joachim Dittrich returns to his former company, previously working for Optima Consumer from 2010 to 2011 as the Commercial Director.

You may also like

Analysis

Landmark installation for the Vapourtec E-Series system

The landmark spreads the use of E-Series to 20 nations and comes in four standard configurations: easy-Scholar, easy-Polymer, easy-Medchem and easy-Photochem
Digital

Qinecsa Solutions acquires Insife to expand its pharmacovigilance technology solutions

The HALOPV platform developed by Insife is considered a safety database with multivigilance capabilities and more, as it covers the end-to-end management of PV processes
Digital

Real-time data insights powered by digital transformation

The most trailblazing contract development and manufacturing organisations (CDMOs) are at the forefront of digital transformation, leveraging it to offer unparalleled customer service through operational streamlining and the provision of insights
Manufacturing

The future of industrial automation in chemicals

The chemical industry is a large and diverse sector that manufactures a wide range of products, including fibres, plastics, surface finishes and pharmaceutical excipients. Agriculture, construction, transportation, healthcare and consumer goods are just a few sectors that use such chemical products
Research & Development

SimBioSys and General Inception partner to accelerate cancer drug development

PhenoScope, SimBioSys' proprietary digital technology, can cut drug development time and costs significantly
Manufacturing

Implementing a “low/no code” automated process control system

Never before has the world seen such great progress in digital technology; we are at the forefront of breakthrough innovations, systems and processes that are facilitating the development of incredible products for our communities. Yet, with these advances, many companies in the life sciences and pharmaceutical industries are experiencing growth pains
Analysis

Estonia National Biobank selects PacBio to sequence 10,000 whole genomes

HiFi data generated on the Revioä system will support the EU and Estonian government-funded centre for personalised medicine
Subscribe now